Allergy Therapeutics (AGY)

 

Latest News

Allergy Therapeutics to Present at Jefferies 2017

RNS Number: 2495W Allergy Therapeutics PLC 13 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics to Present at Jefferies 2017 London Healthcare Conference 13 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces th...

Director/PDMR Shareholding

RNS Number: 8138V Allergy Therapeutics PLC 07 November 2017 The announcement released by Allergy Therapeutics plcentitled "Director/ PDMR Shareholding" on 7 November 2017 at 11:54 incorrectly stated the exercise price as 0.0001 per share. The correct exercise price is 0.001. All other figures remain unchanged. The correct figure is included in the reissued ann...

Director/PDMR Shareholding

RNS Number: 8006V Allergy Therapeutics PLC 07 November 2017 07 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Grant of Options under Long Term Incentive Plan Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that certain performance c...

Publication of Annual Report and notice of AGM

RNS Number: 1267U Allergy Therapeutics PLC 19 October 2017 19 October 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") ANNUAL FINANCIAL REPORT 2017 AND NOTICE OF 2017 ANNUAL GENERAL MEETING Allergy Therapeutics Plc has today published the following documents: Annual Report for the year ended 30 June 201...

All News

DateHeadlineSource
17-09-12Final ResultsRNS
30-08-12Notice of results and shareholder updateRNS
03-08-12Markets: FTSE 100 climbs higher on FridayInteractive Investor
03-08-12FDA Clinical Hold LiftedRNS
31-05-12Holding(s) in CompanyRNS
23-05-12Voluntary recall of Anapen by Lincoln MedicalRNS
17-05-12Holding(s) in CompanyRNS
17-05-12Holding(s) in CompanyRNS
16-05-12Total Voting RightsRNS
02-05-12Board AppointmentRNS
24-04-12Holding(s) in CompanyRNS
20-04-12Concert Party ShareholdingRNS
20-04-12Director/PDMR ShareholdingRNS
19-04-12Result of AGMRNS
18-04-12Markets: FTSE 100 uncertain on WednesdayInteractive Investor
18-04-12Result of OfferRNS
30-03-12Grant of OptionsRNS
30-03-12Fundraising AnnouncementRNS
30-03-12Half Yearly ReportRNS
14-03-12Notice of results and shareholder updateRNS
21-02-12Holding(s) in CompanyRNS
21-02-12Holding(s) in CompanyRNS
06-12-11Markets: FTSE 100 flat on TuesdayInteractive Investor
08-06-11Regulatory UpdateRNS
28-04-11Total Voting RightsRNS
26-04-11Markets: Manufacturing data lifts FTSE 100Interactive Investor
26-04-11FDA approval lifts shares in Allergy TherapeuticsInteractive Investor
26-04-11FDA UpdateRNS
20-04-11Exercise of OptionsRNS
11-04-11Holding(s) in CompanyRNS
11-04-11Holding(s) in CompanyRNS
07-04-11Grass MATA MPL dossier submitted in SwitzerlandRNS
06-04-11Allergic rhinitis vaccination website launchedRNS
30-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
28-03-11Markets: FTSE 100 trims gains on MondayInteractive Investor
28-03-11U.S. regulatory updateRNS
28-03-11Half Yearly ReportRNS
09-02-11Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account